Prelude Capital Management, LLC Astrazeneca PLC Call Options Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$55.56 - $60.79 $4.17 Million - $4.56 Million
-75,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$48.42 - $60.18 $3.63 Million - $4.51 Million
75,000 New
75,000 $4.49 Million
Q3 2020

Nov 16, 2020
SELL
$53.07 - $61.1 $26,535 - $30,550
-500 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$43.1 - $55.31 $21,550 - $27,655
500 New
500 $26,000

Others Institutions Holding AZN

# of Institutions
1,334
Shares Held
490M
Call Options Held
4.99M
Put Options Held
3.19M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email